Is this a real specialty clinic case study?

No. This is a buyer-education and evidence-pack page. It does not claim a real clinic, patient data, PHI, client result, testimonial, ranking, revenue, prior-authorization speed improvement or denial reduction.

Does AICS submit prior authorizations or provide payer advice?

No. AICS maps operating evidence, queue ownership and safe dashboard requirements. Qualified clinic, payer, legal, privacy, security and clinical advisers must decide obligations, payer workflows and production controls.

How does this differ from patient access, revenue-cycle or AI calling tools?

AICS should be positioned as the proof-before-platform layer: it maps source-to-owner leakage, ageing queues, missing evidence, escalation boundaries and leadership review cadence before buying or replacing operational software.

North America · Patient GrowthOS · prior authorization evidence

US specialty clinic prior authorization evidence pack

For practice owners, COOs and patient-access leaders who suspect referrals, prior authorizations, eligibility checks, insurance calls and patient callbacks are ageing across EHR notes, portals, spreadsheets, faxes, call centers and staff inboxes.

Request diagnostic scope → View leakage checklist

Region selected

Current run focus: North America / US Eastern business morning. At research time it was 10:39 EDT, an active window for US clinic administrators and revenue-cycle leaders.

Buyer pain language

prior authorization automationpatient accessreferral leakageeligibility verificationpayer follow-upspecialty clinic schedulingrevenue cycleAI healthcare agents

Search visibility gap

Bing returned HTTP 200 for sampled pain queries, but readable results did not show an AICS marker. AICS needs more top-of-funnel proof pages that speak prior-auth and patient-access language without claiming outcomes.

Competitor landscape AICS must respect

Public pages sampled by HTTP on 2026-08-21 for vocabulary only; this is not an endorsement, partnership, certification or ranking claim.

Recognized option	Public language observed	AICS top-3/top-5 implication
Notable	Patient access, referrals, automation, engagement, revenue cycle and AI language.	Do not claim platform parity. Publish evidence-room and owner-dashboard artifacts around the workflow.
Luma Health	Patient access, scheduling, referral, automation, engagement, eligibility, calls and AI language.	Use patient-journey and queue-ageing vocabulary; show what is unowned before automation.
Phreesia	Scheduling, referral, eligibility, calls and AI-related language on accessible pages.	AICS should avoid no-show/revenue promises and instead show measurement design and safe data minimisation.
Artera	Scheduling, referral, calls and AI-agent language.	AICS can be the escalation-boundary and evidence-readiness layer around communication automation.
Infinitus / Rivet / Kyruus Health / Experian-style RCM tools	Insurance-call automation, eligibility, prior-auth/revenue-cycle or healthcare engagement vocabulary appeared across accessible or searched pages; one Experian deep URL returned 403 and was not used for detailed claims.	AICS must not act as a payer automation vendor. It should map what evidence, owner and status fields the clinic needs before tool spend.

Evidence fields a credible prior-auth diagnostic should publish

1. Request inventory

Source, specialty, payer category, referral channel, received timestamp, patient-access status and minimum necessary identifier policy.

2. Owner and ageing map

Named accountable owner, current queue, 0–2 hour / same-day / 1–2 day / 3–5 day / over-5-day ageing and blocked reason.

3. Prior-auth status taxonomy

Not started, info missing, submitted, payer pending, patient pending, approved, denied, appealed, scheduled, cancelled and closed with reason.

4. AI and human-boundary log

Which messages can be automated, which require staff review, and which must escalate for medical, emergency, payer, privacy, security or legal questions.

5. Patient-access handoff proof

Whether scheduling, eligibility, intake, benefits, clinical review and follow-up teams can see the same status and next action.

6. Executive decision queue

Weekly owner view of stuck work by source, payer, age, owner, blocker, evidence gap and safe next action before approving more software.

What AICS must publish/build next to become top-5 credible

Downloadable sample CSV: clearly labelled demo fields for prior-auth and referral queue mapping, with no PHI.
Before/after diagnostic example: simulated only, showing how queue evidence changes decision-making without claiming speed, revenue or denial outcomes.
Neutral comparison: AICS vs patient engagement, AI calling, intake, EHR portal, RCM, prior-auth and call-center options.
HIPAA-boundary FAQ: operational questions to take to qualified privacy/security/legal advisers, not a compliance claim.
Owner dashboard mockup: prior-auth queue, referral leakage, patient-access handoffs and escalation boundaries visible in one review cadence.

Claim boundary

This page is not a real US specialty clinic case study, not a testimonial, not a prior-authorization submission service, not payer-contracting advice, not medical advice, not legal advice, not privacy advice, not security advice and not proof of HIPAA compliance, authorization-speed improvement, denial reduction, patient outcome, booked visits, revenue, ROI, ranking, ad performance, certification, official platform partnership or AI accuracy. Demos must be labelled demo/internal/simulated/synthetic unless Raj approves real evidence.

FAQ

Should AICS contact clinics from this run?: No. Raj’s corrected strategy is asset and visibility first. No outreach was sent.
Can this be used as a package page?: Yes, as a buyer-education and diagnostic-scope page. Keep all boundaries intact and do not imply a real client result.
Where does this fit in Healthcare GrowthOS?: It is a Patient GrowthOS proof-before-platform asset for clinics whose patient-access, referral and prior-auth work is split across tools and owners.

Healthcare GrowthOS · US healthcare comparison · US clinic proof pack · Evidence policy